Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,513Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1BAYER HLTHCARE

02 107MAYNE PHARMA

03 16NOVEN

04 7SUMITOMO PHARMA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

DROSPIRENONE; ESTRADIOL

US Patent Number : 8906890

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21355

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-10-22

blank

02

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

ESTRADIOL; PROGESTERONE

US Patent Number : 10206932

Drug Substance Claim :

Drug Product Claim :

Application Number : 210132

Patent Use Code : U-2439

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-21

blank

03

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

ESTRADIOL; PROGESTERONE

US Patent Number : 8846649

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210132

Patent Use Code : U-2439

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-21

blank

04

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

ESTRADIOL; PROGESTERONE

US Patent Number : 8846648

Drug Substance Claim :

Drug Product Claim :

Application Number : 210132

Patent Use Code : U-2439

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-21

blank

05

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

ESTRADIOL; PROGESTERONE

US Patent Number : 9114146

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210132

Patent Use Code : U-2439

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-21

blank

06

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

ESTRADIOL

US Patent Number : 10258630

Drug Substance Claim :

Drug Product Claim :

Application Number : 208564

Patent Use Code : U-2316

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-12-20

blank

07

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

ESTRADIOL

US Patent Number : 10258630

Drug Substance Claim :

Drug Product Claim :

Application Number : 208564

Patent Use Code : U-2316

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-12-20

blank

08

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

ESTRADIOL

US Patent Number : 10258630

Drug Substance Claim :

Drug Product Claim :

Application Number : 208564

Patent Use Code : U-2317

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-12-20

blank

09

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

ESTRADIOL; PROGESTERONE

US Patent Number : 9114145

Drug Substance Claim :

Drug Product Claim :

Application Number : 210132

Patent Use Code : U-2439

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-21

blank

10

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

ESTRADIOL

US Patent Number : 10398708

Drug Substance Claim :

Drug Product Claim :

Application Number : 208564

Patent Use Code : U-2317

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-12-20

blank